These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1077 related articles for article (PubMed ID: 7194136)

  • 1. Correlation between plasminogen activator activity of immunizing tumor cells and complement-mediated cytotoxic antibodies secreted by cloned hybrid cells.
    Hakim AA
    Cancer Biochem Biophys; 1980; 5(1):63-74. PubMed ID: 7194136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol-induced release of immunosuppressive agent from human malignant melanoma cells.
    Hakim AA
    Ann Immunol (Paris); 1980; 131C(2):155-70. PubMed ID: 7416716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
    Newcomb EW; Silverstein SC; Silagi S
    J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible suppression of malignancy and differentiation of melanoma cells.
    Silagi S
    Am J Pathol; 1977 Dec; 89(3):671-84. PubMed ID: 596422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estradiol and degree of cell differentiation on human melanoma susceptibility to killing by monoclonal antibodies.
    Hakim AA
    Immunol Lett; 1982 Jan; 4(1):59-64. PubMed ID: 7061114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-cultivation of tumorigenic mouse melanoma cells with cells of a non-tumorigenic subclone inhibits plasminogen activator expression by the melanoma cells.
    Kyner D; Christman J; Acs G; Silagi S; Newcomb EW; Silverstein SC
    J Cell Physiol; 1978 May; 95(2):159-67. PubMed ID: 206566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.
    de Vries TJ; Kitson JL; Silvers WK; Mintz B
    Cancer Res; 1995 Oct; 55(20):4681-7. PubMed ID: 7553649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estradiol-induced biochemical changes in human neoplastic cells: estradiol-mediated protease.
    Hakim AA
    Cancer Biochem Biophys; 1980; 4(3):173-82. PubMed ID: 7002285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological and immunochemical analysis of the specificity of xenoantiserum 8986 elicited with hybrids between human melanoma cells and murine fibroblasts.
    Imai K; Galloway DR; Ferrone S
    Cancer Res; 1981 Mar; 41(3):1028-33. PubMed ID: 6161692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to human tumor antigens.
    Steplewski Z
    Transplant Proc; 1980 Sep; 12(3):384-7. PubMed ID: 7222217
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
    de Vries TJ; Quax PH; Denijn M; Verrijp KN; Verheijen JH; Verspaget HW; Weidle UH; Ruiter DJ; van Muijen GN
    Am J Pathol; 1994 Jan; 144(1):70-81. PubMed ID: 8291613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to human melanoma-associated antigens.
    Imai K; Molinaro GA; Ferrone S
    Transplant Proc; 1980 Sep; 12(3):380-3. PubMed ID: 7222216
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activators in nude mice xenotransplanted with human tumorigenic cells.
    Colombi M; Bellotti D; De Petro G; Barlati S
    Invasion Metastasis; 1995; 15(1-2):22-33. PubMed ID: 7672929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator and metalloprotease activities of Du-145, PC-3, and 1-LN-PC-3-1A human prostate tumors grown in nude mice: correlation with tumor invasive behavior.
    Wilson MJ; Sinha AA
    Cell Mol Biol Res; 1993; 39(8):751-60. PubMed ID: 7951414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
    Lockwood CJ
    Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
    Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
    Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of urokinase plasminogen activator (uPA) activity by E-cadherin and hormones in mammary epithelial cells.
    Sasaki CY; Lin H; Passaniti A
    J Cell Physiol; 1999 Oct; 181(1):1-13. PubMed ID: 10457348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.